Lymphogranuloma venereum historical perspective

Lymphogranuloma venereum Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Classification
Differentiating Lymphogranuloma venereum from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Lymphogranuloma venereum historical perspective On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Lymphogranuloma venereum historical perspective All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Lymphogranuloma venereum historical perspective
CDC on Lymphogranuloma venereum historical perspective
Lymphogranuloma venereum historical perspective in the news
Blogs on Lymphogranuloma venereum historical perspective
Directions to Hospitals Treating Lymphogranuloma venereum
Risk calculators and risk factors for Lymphogranuloma venereum historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nate Michalak, B.A.

Overview

Lymphogranuloma venereum was described first by Wallace in 1833 and again by Durand, Nicolas, and Favre in 1913.

Historical Perspective

• Lymphogranuloma venereum (LGV) was first described by Wallace in 1833.
• Clinical aspects of LGV were described by N. Joseph Durand, Maurice Favre, and Joseph Nicolas in 1913.